Case Report Renal Failure Associated with Hydantoins Administration in Nutritional Rickets

  • Ricardo Gastelbondo-Amaya
  • Ricardo Mun̂oz-Arizpe
  • Felipe Mota-Hernández
  • Gustavo Gordillo-Paniagua


The clinical presentation of bone disease and renal failure in a given patient strongly suggests a close relationship between both entities, rickets being secondary to long standing renal failure.


Renal Osteodystrophy Calcium Gluconate Tubulointerstitial Nephritis Percutaneous Renal Biopsy Nutritional Rickets 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Avioli, V.L. and Teitelbaum, L.S.: Renal osteodystrophies. In Brenner, B.M., Rector, F.C. (eds.): The Kidney. Philadelphia: W.B. Saunders, 1976, 1542.Google Scholar
  2. 2.
    Beale, G.M., Salcedo, J.R. and Ellis, D. et al.: Renal osteodystrophy. In Chan, J.C.M. (ed.): The Pediatric Clinics of North America. Pediatric Nephrology. Philadelphia: W.B. Saunders, 1976, 885.Google Scholar
  3. 3.
    Nielsen, H.E., Romer, F.K. and Meisen, F. et al.: 1-hydroxi-vitamin D3 treatment of non-dialyzed patients with chronic renal failure. Effects on bone, mineral metabolism and kidney function. Clin. Nephrol. 13: 103, 1980.PubMedGoogle Scholar
  4. 4.
    Brickman, A.S., Sherrard, D.J., Jomsey, J. et al.: 1, 25-dihydroxicholecalciferol. Effect on skeletal lesions and plasma parathyroid hormone levels in uremic osteodystrophy. Arch. Intern. Med.Google Scholar
  5. 5.
    Alfrey, C.A.: Chronic renal failure: manifestations and pathogenesis. In Schrier, R.W. (ed.): Renal and Electrolyte Disorders. Boston: Little, Brown, 1976, 319.Google Scholar
  6. 6.
    Heptinstall, R.H.: Pathology of the Kidney. 2nd Ed. Boston: Little, Brown, 1976.Google Scholar
  7. 7.
    Michel, J.R. and Mitch, W.E.: Reversible renal failure and myositis caused by phenylhydantoin hypersensitivity. JAMA 236: 2773, 1976.CrossRefGoogle Scholar
  8. 8.
    Hyman, L.R., Ballow, M. and Knieser, M.R.: Diphenylhydantoin nephropathy. Evidence for an autoimmune pathogenesis. Kidney Int. 8: 450, 1975.Google Scholar
  9. 9.
    Popovtzer, M.M.: Disorders of calcium, phosphorus, vitamin D and parathyroid hormone activity. In Schrier, R.W. (ed.): Renal and Electrolyte Disorders. Boston: Little, Brown, 1976, 167.Google Scholar
  10. 10.
    Stamp, T.C.B., Round, J.M., Rome, D.J.F. et al.: Plasma levels and therapeutic effect of 25-hydroxicholecalciferol in epileptic patients taking anticonvulsant drugs. Br. Med. J. 4: 9, 1972.PubMedCrossRefGoogle Scholar
  11. 11.
    Richens, A. and Rome, D.J.F.: Disturbance of calcium metabolism by anticonvulsant drugs. Br. Med. J. 4: 73, 1970.PubMedCrossRefGoogle Scholar
  12. 12.
    Pierides, A.M., Kerr, D.N.S. and Ellis, H.A.: 1 alpha-hydroxy-cholecalciferol in hemodialysis renal osteodystrophy. Adverse effects of anticonvulsant therapy. Clin. Nephrol. 5: 189, 1976.Google Scholar
  13. 13.
    Barnes, L.A.: Nutritional disorders. In Vaughn, V.C. and McKay, R.J. (eds.): Nelson Textbook of Pediatrics. Philadelphia: W.B. Saunders, 1975, 183.Google Scholar

Copyright information

© Plenum Press, New York 1981

Authors and Affiliations

  • Ricardo Gastelbondo-Amaya
    • 1
  • Ricardo Mun̂oz-Arizpe
    • 1
  • Felipe Mota-Hernández
    • 1
  • Gustavo Gordillo-Paniagua
    • 1
  1. 1.Dept. Nephrol.Hosp. InfantilMéxico CityMéxico

Personalised recommendations